Speeding Up Beta-Blockade Prior To Coronary Ct Angiography: Can We Predict The Dose Of Intravenous Metoprolol Required To Achieve Target Heart Rate In A Given Patient?

AIM: To evaluate the use and safety of intravenous (IV) metoprolol in a cohort of patients undergoing coronary computed tomographic angiography (CCTA) at a university hospital, and in particular, to establish if the minimum dose required to achieve the target heart rate (HR) in a given patient can be predicted from the baseline HR.MATERIALS AND METHODS: Patients undergoing CCTA at a tertiary centre between January 2015 and May 2018, with baseline HR >= 60 bpm requiring IV metoprolol, were identified retrospectively from the database. Patients with a contraindication to beta-blockade or an indication for CCTA other than coronary disease were excluded. HR at baseline and at the time of scanning were recorded, together with the total dose of IV metoprolol administered.RESULTS: Of 625 patients identified, 330 (52.8%) achieved HR <= 60 with IV metoprolol. Patients who achieved target HR had lower baseline HR. They received a lower radiation exposure due to tight prospective gating and a lower tube voltage. The lower quartile dose of metoprolol administered was 5 mg for patients with baseline HR <65 beats per minute (bpm), but 10 mg for HR 65-74 bpm, and >= 20 mg for higher HRs. There were no cases of symptomatic bradycardia/hypotension.CONCLUSION: Patients with a resting HR of >= 60 bpm can reasonably be given an initial minimum dose of 5-20 mg metoprolol IV before CCTA, with additional doses as required. (C) 2020 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.